Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2
About this item
Full title
Author / Creator
Sattler, Arne , Schrezenmeier, Eva , Weber, Ulrike A , Potekhin, Alexander , Bachmann, Friederike , Straub-Hohenbleicher, Henriette , Budde, Klemens , Storz, Elena , Pross, Vanessa , Bergmann, Yasmin , Thole, Linda M.L , Tizian, Caroline , Holsken, Oliver , Diefenbach, Andreas , Schrezenmeier, Hubert , Jahrsdorfer, Bernd , Zemojtel, Tomasz , Jechow, Katharina , Conrad, Christian , Lukassen, Soren , Stauch, Diana , Lachmann, Nils , Choi, Mira , Halleck, Fabian and Kotsch, Katja
Publisher
American Society for Clinical Investigation
Journal title
Language
English
Formats
Publication information
Publisher
American Society for Clinical Investigation
Subjects
More information
Scope and Contents
Contents
Novel mRNA-based vaccines have been proven to be powerful tools in combating the global pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently protecting individuals from COVID-19 across a broad age range. Still, it remains largely unknown how renal insufficiency and immunosuppressive medication affect development of vacci...
Alternative Titles
Full title
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2
Authors, Artists and Contributors
Author / Creator
Schrezenmeier, Eva
Weber, Ulrike A
Potekhin, Alexander
Bachmann, Friederike
Straub-Hohenbleicher, Henriette
Budde, Klemens
Storz, Elena
Pross, Vanessa
Bergmann, Yasmin
Thole, Linda M.L
Tizian, Caroline
Holsken, Oliver
Diefenbach, Andreas
Schrezenmeier, Hubert
Jahrsdorfer, Bernd
Zemojtel, Tomasz
Jechow, Katharina
Conrad, Christian
Lukassen, Soren
Stauch, Diana
Lachmann, Nils
Choi, Mira
Halleck, Fabian
Kotsch, Katja
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_incontextgauss_ISR_A669344438
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_incontextgauss_ISR_A669344438
Other Identifiers
ISSN
0021-9738
DOI
10.1172/JCI150175
